Mounjaro – Weight loss injections

You may have seen media coverage about a new drug which is expected to be made available to a limited number of patients over the coming year.

NICE – the National Institute for Health and Care Excellence, which advises the NHS on use of medicines – is expecting to approve Mounjaro (also known as Tirzepatide) for some patients from March 2025.

This will initially include only people who have the most serious need for this medication, based on body mass index (BMI) and having at least one obesity-related health problem. It will be provided along with extra support and advice to help patients improve their diet and exercise, which is vital to maintaining a healthy weight in the long term.

It’s important to bear in mind that medicines are not the only way to improve your weight, fitness and health, and for many people they are not the best option.

Our specialist weight management services offer a wide range of support to help patients find a sustainable solution to weight problems. We are working to urgently expand these services, as we know waiting lists are currently longer than we would all like. Our GP practices are currently receiving a high level of enquiries about weight loss drugs.

Click the link for self referral: Weight loss medicines and lifestyle changes

The Integrated Care Board (ICB) will get back in touch with the patients within 4-6 weeks to invite them to an engagement session to give them more information about the weight loss medicines and next steps.

Published on 8 April 2025